MicroRNA-17, 20a regulates the proangiogenic function of tumor-associated macrophages via targeting hypoxia-inducible...

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Tumor-associated macrophages (TAMs) are key immune cells in solid tumors, often promoting tumor growth via proangiogenic factors.
• The exact mechanisms controlling TAM proangiogenic activity, particularly under non-hypoxic conditions, are not fully understood.

Purpose of the Study:

• To investigate the regulation of hypoxia-inducible factor 2α (HIF-2α) in TAMs.
• To elucidate the role of microRNAs (miRNAs) and cytokines in modulating HIF-2α expression and subsequent proangiogenic activity in TAMs.

Main Methods:

• Analysis of HIF-2α expression in TAMs from solid tumors and in macrophages treated with tumor supernatant.
• Identification of regulatory miRNAs (miR-17, miR-20a) and cytokines (IL-6) involved in HIF-2α modulation.
• Assessment of HIF-2α's impact on proangiogenic gene expression (VEGFA, PDGFB).

Main Results:

• HIF-2α expression was significantly elevated in TAMs from various solid tumors and in macrophages exposed to tumor supernatants, independent of hypoxia.
• miR-17 and miR-20a were identified as key regulators of HIF-2α in TAMs.
• Autocrine IL-6 signaling mediated the expression of miR-17, miR-20a, and subsequently HIF-2α.
• Elevated HIF-2α in TAMs stimulated the transcription of proangiogenic genes like VEGFA and PDGFB.

Conclusions:

• HIF-2α plays a critical role in the proangiogenic function of TAMs.
• A novel mechanism involving miRNAs regulating TAM function via HIF-2α modulation under non-hypoxic conditions was revealed.
• These findings highlight a new pathway for targeting TAMs to inhibit tumor angiogenesis.